<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03074253</url>
  </required_header>
  <id_info>
    <org_study_id>2014-615N-MA</org_study_id>
    <nct_id>NCT03074253</nct_id>
  </id_info>
  <brief_title>Cardiovascular Imaging and Biomarker Analyses (CIBER)</brief_title>
  <acronym>CIBER</acronym>
  <official_title>Cardiovascular Imaging and Biomarker Analyses (CIBER)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      &quot;Cardiovascular Imaging and Biomarker Analyses (CIBER)&quot; is a single-center, prospective and
      observational study evaluating the expression of novel biomarkers in patients undergoing
      cardiacvascular imaging within clinical routine care. It is aimed to evaluate associations
      with biomarker expressions with ascertained cardiac imaging parameters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      &quot;Cardiovascular Imaging and Biomarker Analyses (CIBER)&quot; is a single-center, prospective and
      observational study evaluating the expression of novel biomarkers in patients undergoing
      cardiacvascular imaging within clinical routine care. It is aimed to evaluate associations
      with biomarker expressions with ascertained cardiac imaging parameters. Furthermore the
      prognostic value of biomarkers and imaging parameters on mid-term and long-term prognosis
      will be evaluated. Novel biomarkers will comprise blood derived biomarkers including
      neurohormones, proteins, cytokines, microRNAs and metabolomics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2014</start_date>
  <completion_date type="Anticipated">July 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Biomarker levels before cardiac imaging</measure>
    <time_frame>24 hours before cardiac imaging</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Heart Diseases</condition>
  <condition>Heart Failure</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <description>Patients are undergoing echocardiography</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>magnetic resonance imaging</intervention_name>
    <description>Patients are undergoing magnetic resonance imaging</description>
    <other_name>MRI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>computed tomography</intervention_name>
    <description>Patients are undergoing computed tomography</description>
    <other_name>CT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood withdrawl</intervention_name>
    <description>Peripheral blood samples are being collected from all patients</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      One peripheral blood withdraws in EDTA, citrate, ammonium heparin, serum tubes within 24
      hours before cardiac imaging.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing cardiac imaging (i.g. echocardiography, cardiac MRI, cardiac CT) within
        the clinical routine.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with low to intermediate risk for coronary artery disease

        Exclusion Criteria:

          -  under 18 years

          -  mechanical heart valve

          -  pulmonary embolism

          -  deep vein thrombosis

          -  myocardial infarction within the last 3 months

          -  electrical cardioversion within 30 days

          -  status after heart transplant

          -  transient ischemic attack (TIA) or stroke within last 30 days

          -  intracerebral bleeding within the last 2 months

          -  acute infection

          -  existing or planned pregnancy

          -  chronic kidney disease with eGFR &lt; 40 ml/min
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ibrahim Akin, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University Medical Center Mannheim</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ibrahim Akin, Prof. Dr.</last_name>
    <phone>0049 621 383 5229</phone>
    <email>ibrahim.akin@umm.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Behnes, Dr.</last_name>
    <phone>0049 621 383 6239</phone>
    <email>michael.behnes@umm.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Department of Medicine, University Medical Centre Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ibrahim Akin, MD, PhD</last_name>
      <email>ibrahim.akin@umm.de</email>
    </contact>
    <contact_backup>
      <last_name>Michael Behnes, MD</last_name>
      <email>michael.behnes@umm.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kim SH, Behnes M, Natale M, Hoffmann J, Reckord N, Hoffmann U, Budjan J, Henzler T, Papavassiliu T, Borggrefe M, Bertsch T, Akin I. Galectin-3 Reflects Mitral Annular Plane Systolic Excursion Being Assessed by Cardiovascular Magnetic Resonance Imaging. Dis Markers. 2016;2016:7402784. doi: 10.1155/2016/7402784. Epub 2016 Dec 1.</citation>
    <PMID>28044067</PMID>
  </reference>
  <reference>
    <citation>Behnes M, Lang S, Breithardt OA, Kaden JJ, Haghi D, Ahmad-Nejad P, Elmas E, Wolpert C, Borggrefe M, Neumaier M, Brueckmann M. Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema. J Heart Valve Dis. 2008 Sep;17(5):557-65.</citation>
    <PMID>18980090</PMID>
  </reference>
  <reference>
    <citation>Behnes M, Bertsch T, Weiss C, Ahmad-Nejad P, Akin I, Fastner C, El-Battrawy I, Lang S, Neumaier M, Borggrefe M, Hoffmann U. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients. Int J Cardiol. 2016 Jan 15;203:398-406. doi: 10.1016/j.ijcard.2015.10.127. Epub 2015 Oct 20.</citation>
    <PMID>26539964</PMID>
  </reference>
  <reference>
    <citation>Behnes M, Brueckmann M, Lang S, Espeter F, Weiss C, Neumaier M, Ahmad-Nejad P, Borggrefe M, Hoffmann U. Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure. Eur J Heart Fail. 2013 Dec;15(12):1390-400. doi: 10.1093/eurjhf/hft112. Epub 2013 Jul 12.</citation>
    <PMID>23851388</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2017</study_first_submitted>
  <study_first_submitted_qc>March 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>March 7, 2017</last_update_submitted>
  <last_update_submitted_qc>March 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Michael Behnes</investigator_full_name>
    <investigator_title>Dr. med</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

